Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Ribavirin | Ribavirin | 2004-10-04 | |||
Ribavirin | Ribavirin Teva | 2009-03-31 | ||||
Ribavirin | Ribavirin Teva Pharma B.V | 2009-07-01 | ||||
Sofosbuvir | Sofosbuvir | 2022-01-27 | ||||
Mylan | Ribavirin | Ribavirin Mylan (previously Ribavirin Three Rivers) | 2010-06-10 | |||
Johnson & Johnson | Telaprevir | Incivo | 2011-09-19 | |||
Simeprevir | Olysio | 2025-05-19 | 2013-11-22 | |||
Roche | Ribavirin | Copegus | 2002-12-03 | |||
Ribavirin, Peginterferon alfa-2a | Pegasys Copegus | 2004-06-04 | ||||
Interferon alfa-2a | Roferon-A | 1986-06-04 | ||||
Sandoz | Ribavirin | Ribavirin | 2006-10-03 | |||
AbbVie | Dasabuvir | Exviera | 2015-01-14 | |||
Glecaprevir, Pibrentasvir | Maviret | 2017-07-26 | ||||
Ritonavir, Ombitasvir, Paritaprevir | Technivie | 2024-08-25 | 2015-07-24 | |||
Ritonavir, Dasabuvir, Ombitasvir, Paritaprevir | Viekira | 2024-08-25 | 2014-12-19 | $16 M | Q2/19-Q1/20 | |
Ritonavir, Ombitasvir, Paritaprevir | Viekirax | 2015-01-14 | ||||
Bausch Health Companies | Ribavirin | Virazole | 1985-12-31 | |||
Merck & Co | Ribavirin | Cotronak | 1999-05-07 | |||
Interferon alfa-2b | Intron A | 1986-06-04 | ||||
Interferon alfa-2b | IntronA | 2000-03-09 | ||||
Peginterferon alfa-2b | PegIntron | 2001-01-19 | ||||
Ribavirin, Peginterferon alfa-2b | PegIntron/ Rebetol Combo Pack | 2008-06-13 | ||||
Ribavirin | Rebetol | 1998-06-03 | ||||
Boceprevir | Victrelis | 2024-12-22 | 2011-05-13 | |||
Interferon alfa-2b | Viraferon | 2000-03-09 | ||||
Peginterferon alfa-2b | ViraferonPeg | 2000-05-28 | ||||
Elbasvir, Grazoprevir | Zepatier | 2029-07-24 | 2016-01-28 | $167 M | Y2020 | |
Aurobindo Pharma | Ribavirin | Ribavirin | 2009-09-17 | |||
Zydus Therapeutics | Ribavirin | Ribavirin | 2005-12-05 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|